The aim of this study was to investigate the serum levels of MaR1 and CHI3L1 and their relationship with inflammatory parameters such as NLR and PLR in patients with T2DM and diabetic nephropathy. Here, CHI3L1 is linked to type 2 diabetes mellitus.